All articles tagged with #most favored nation
A new Kaiser Family Foundation analysis shows that the TrumpRx platform delivers mixed results for prescription drug prices. While 17 brand-name drugs cost less than the average in peer countries, 15 are more expensive, and 13 are the most costly among all compared nations. The administration claims $700 million in savings, but experts advise patients to compare prices with insurance and other discount programs.
A new analysis by the Kaiser Family Foundation (KFF) reveals that the TrumpRx website delivers mixed results for Americans seeking lower prescription drug prices. While prices for 17 brand-name drugs are lower than the average in 11 peer nations, 15 drugs cost significantly more. The site, which targets cash-paying consumers, does not guarantee the 'lowest prices in the developed world' as claimed by the administration. Notable exceptions include weight-loss drugs like Ozempic and Zepbound, which remain more expensive in the U.S. than in comparable countries. This finding contrasts with the administration's broader 'most favored nation' strategy, which has secured deals with 26 pharmaceutical companies and enrolled all 50 states in Medicaid pricing reforms.
The White House announced nine additional MFN-style drug-pricing deals with pharma firms (bringing total to 26) intended to lower prices for Medicaid and align U.S. prices with other wealthy nations; details are largely confidential, prompting calls from Democrats for transparency. The administration also highlights the Medicare GLP-1 Bridge Program, which has saved seniors money, and urges Congress to codify MFN pricing into permanent law.
President Trump is set to announce that about a dozen drugmakers will voluntarily lower prices on outpatient drugs, expanding the administration’s push to tie U.S. prices to cheaper foreign rates under its 'most favored nation' policy. The effort follows deals with roughly 17 pharma companies over the past year and a May 2025 executive order reviving the policy. Participating manufacturers would offer discounts to state Medicaid programs (optional participation) and may be exempt from Medicare discount pilots, as part of a broader strategy to curb healthcare costs ahead of elections, while drugmakers expand direct-to-consumer channels such as the TrumpRx portal.
President Trump launched TrumpRx.gov, a government platform using Most-Favored-Nation pricing to dramatically reduce costs on dozens of brand-name drugs, with substantial cuts for GLP-1 therapies and fertility medications and plans to add more drugs over time. The White House says the initiative could be codified and expanded through a forthcoming Great Healthcare Plan, potentially extending coverage to TrumpRx.gov purchases and lowering insurance costs for Americans.
Several drug companies have agreed to lower their drug prices through 'Most Favored Nation' deals with the Trump administration, following initial hesitation from pharmaceutical executives after President Trump called for voluntary price cuts in May.
President Trump announced new 'Most Favored Nation' drug pricing deals with nine pharmaceutical companies to lower drug costs and plans to meet with insurers to address rising health insurance premiums, amid skepticism about the impact of these measures.
The Trump administration's CMS is launching a five-year pilot in 2026 to link Medicaid drug prices to lower international prices through a 'Most Favored Nation' model, allowing participating states to negotiate lower prices for certain drugs, amid ongoing debates about its impact on drug costs and rebates.
President Trump claims to have reduced drug prices by up to 1,500%, but experts say such reductions are mathematically impossible. His efforts focus on aligning US drug prices with those in peer countries through voluntary agreements and potential government enforcement, alongside other initiatives like tariffs and reforming drug supply chain policies. However, significant policy changes require time and cooperation from multiple stakeholders in the healthcare system.